Search

Catherine R. Oliver-garcia

Examiner (ID: 9259, Phone: (571)272-2655 , Office: P/2914 )

Most Active Art Unit
2914
Art Unit(s)
2904, 2900, 2914
Total Applications
7479
Issued Applications
7429
Pending Applications
0
Abandoned Applications
54

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6544609 [patent_doc_number] => 20020137679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'COMP/TSP-1, COMP/TSP-2 and other TSP chimeric proteins' [patent_app_type] => new [patent_app_number] => 09/919603 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8018 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137679.pdf [firstpage_image] =>[orig_patent_app_number] => 09919603 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/919603
COMP/TSP-1, COMP/TSP-2 and other TSP chimeric proteins Jul 29, 2001 Abandoned
Array ( [id] => 6715796 [patent_doc_number] => 20030027144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Tumor antigen-derived gene 16 (TADG-16): a novel extracellular serine protease and uses thereof' [patent_app_type] => new [patent_app_number] => 09/907187 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12114 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027144.pdf [firstpage_image] =>[orig_patent_app_number] => 09907187 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/907187
Tumor antigen-derived gene 16 (TADG-16): a novel extracellular serine protease and uses thereof Jul 16, 2001 Abandoned
Array ( [id] => 1059758 [patent_doc_number] => 06852848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-08 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 09/906646 [patent_app_country] => US [patent_app_date] => 2001-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 124 [patent_figures_cnt] => 124 [patent_no_of_words] => 120230 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852848.pdf [firstpage_image] =>[orig_patent_app_number] => 09906646 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/906646
Secreted and transmembrane polypeptides and nucleic acids encoding the same Jul 15, 2001 Issued
Array ( [id] => 6674226 [patent_doc_number] => 20030059829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/905381 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 125 [patent_figures_cnt] => 125 [patent_no_of_words] => 117829 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059829.pdf [firstpage_image] =>[orig_patent_app_number] => 09905381 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/905381
Secreted and transmembrane polypeptides and nucleic acids encoding the same Jul 12, 2001 Issued
Array ( [id] => 6673829 [patent_doc_number] => 20030059432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Lipophilin complexes for use in cancer diagnosis and therapy' [patent_app_type] => new [patent_app_number] => 09/905673 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22350 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059432.pdf [firstpage_image] =>[orig_patent_app_number] => 09905673 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/905673
Lipophilin complexes for use in cancer diagnosis and therapy Jul 12, 2001 Abandoned
Array ( [id] => 6555506 [patent_doc_number] => 20020111470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/899651 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4153 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111470.pdf [firstpage_image] =>[orig_patent_app_number] => 09899651 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/899651
Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof Jul 5, 2001 Issued
09/869685 Predictive methods based on alpha-1-acid glycoprotein levels Jun 28, 2001 Abandoned
Array ( [id] => 490457 [patent_doc_number] => 07214770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-08 [patent_title] => 'Screening Methods' [patent_app_type] => utility [patent_app_number] => 09/896791 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6344 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/214/07214770.pdf [firstpage_image] =>[orig_patent_app_number] => 09896791 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/896791
Screening Methods Jun 28, 2001 Issued
Array ( [id] => 773173 [patent_doc_number] => 07001735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-21 [patent_title] => 'Glucose transporter/sensor protein and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/886954 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16848 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001735.pdf [firstpage_image] =>[orig_patent_app_number] => 09886954 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/886954
Glucose transporter/sensor protein and uses thereof Jun 20, 2001 Issued
Array ( [id] => 5789580 [patent_doc_number] => 20020161212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells' [patent_app_type] => new [patent_app_number] => 09/887593 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22949 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161212.pdf [firstpage_image] =>[orig_patent_app_number] => 09887593 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/887593
BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells Jun 20, 2001 Abandoned
Array ( [id] => 623793 [patent_doc_number] => 07138501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Antibodies that immunospecifically bind BLyS' [patent_app_type] => utility [patent_app_number] => 09/880748 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 179723 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138501.pdf [firstpage_image] =>[orig_patent_app_number] => 09880748 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/880748
Antibodies that immunospecifically bind BLyS Jun 14, 2001 Issued
Array ( [id] => 6850995 [patent_doc_number] => 20030143198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Method for preparing a physiologically active il-18 polypeptide' [patent_app_type] => new [patent_app_number] => 10/311491 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 8015 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143198.pdf [firstpage_image] =>[orig_patent_app_number] => 10311491 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/311491
Method for preparing a physiologically active IL-18 polypeptide Jun 10, 2001 Issued
Array ( [id] => 5814683 [patent_doc_number] => 20020039735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Monoclonal antibodies to ING1 isoforms' [patent_app_type] => new [patent_app_number] => 09/874347 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5686 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20020039735.pdf [firstpage_image] =>[orig_patent_app_number] => 09874347 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/874347
Monoclonal antibodies to ING1 isoforms Jun 3, 2001 Abandoned
Array ( [id] => 6095313 [patent_doc_number] => 20020051813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Lipomatrix preparation' [patent_app_type] => new [patent_app_number] => 09/870691 [patent_app_country] => US [patent_app_date] => 2001-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5412 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20020051813.pdf [firstpage_image] =>[orig_patent_app_number] => 09870691 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/870691
Lipomatrix preparation May 31, 2001 Abandoned
09/733956 Tnfr-like protein with death domain May 31, 2001 Abandoned
Array ( [id] => 6082286 [patent_doc_number] => 20020082207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Compositions and methods for the therapy and diagnosis of pancreatic cancer' [patent_app_type] => new [patent_app_number] => 09/872153 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34798 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082207.pdf [firstpage_image] =>[orig_patent_app_number] => 09872153 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/872153
Compositions and methods for the therapy and diagnosis of pancreatic cancer May 30, 2001 Abandoned
Array ( [id] => 6891892 [patent_doc_number] => 20010018054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis' [patent_app_type] => new [patent_app_number] => 09/853580 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5524 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018054.pdf [firstpage_image] =>[orig_patent_app_number] => 09853580 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/853580
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis May 13, 2001 Abandoned
Array ( [id] => 776730 [patent_doc_number] => 06998125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-14 [patent_title] => 'Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis' [patent_app_type] => utility [patent_app_number] => 09/853581 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5607 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998125.pdf [firstpage_image] =>[orig_patent_app_number] => 09853581 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/853581
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis May 13, 2001 Issued
Array ( [id] => 6597801 [patent_doc_number] => 20020042363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Nonantigenic stabilizer and physiologically active substance' [patent_app_type] => new [patent_app_number] => 09/849395 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5225 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042363.pdf [firstpage_image] =>[orig_patent_app_number] => 09849395 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/849395
Nonantigenic stabilizer and physiologically active substance May 6, 2001 Abandoned
Array ( [id] => 6519082 [patent_doc_number] => 20020192206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Methods and compositions for angioproliferative disorder treatment' [patent_app_type] => new [patent_app_number] => 09/849115 [patent_app_country] => US [patent_app_date] => 2001-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 8776 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192206.pdf [firstpage_image] =>[orig_patent_app_number] => 09849115 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/849115
Methods and compositions for angioproliferative disorder treatment May 4, 2001 Abandoned
Menu